SOLICITATION NOTICE
68 -- Fresh frozen normal human pancreatic and prostate tissue samples
- Notice Date
- 9/3/2009
- Notice Type
- Presolicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-90241-KM
- Archive Date
- 10/3/2009
- Point of Contact
- Karri L. Mares, Phone: 3014357774, Caren N Rasmussen, Phone: (301) 402-4509
- E-Mail Address
-
maresk@mail.nih.gov, cr214i@nih.gov
(maresk@mail.nih.gov, cr214i@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Laboratory of Translational Genomics (LTG) plans to procure on a sole source basis fresh frozen normal human pancreatic and prostate tissue samples from Cytomyx/OriGene Technologies, Inc., 6 Taft Court, Suite 100, Rockville, MD 20850-5349. This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1 (b)(1). The North American Industry Classification System code is 325413 and the business size standard is 500 employees. The purpose of this acquisition is to purchase 50 fresh frozen normal human pancreatic tissue samples and 100 fresh frozen normal human prostate tissue samples from Cytomyx/OriGene. These samples will be used to develop functional studies to determine the mechanism of gene function and how they are disturbed in disease, and to develop a comprehensive catalogue of gene expression in normal tissue and correlate these levels to genetic variants that are associated with an increased risk of cancer. Delivery of the samples shall be 60 days after date of award. The specifications for tissue samples required for these studies are: The tissue samples must be high quality samples (with no necrosis) collected and stored with rigorous quality control standards and tracked via a robust inventory management system. All tissues must be procured from surgeries and snap frozen within 30 minutes of surgery (arterial ligation) to preserve top quality. Tissue sizes must be 0.2g to 2.0g. All tissues must be frozen in O.C.T. tissue embedding medium. All tissue samples must be from individuals of European ancestry. Each Cytomyx/OriGene tissue piece is unique, as characterized by case and sample ID and backed with an abstracted pathology report unique to each case. Each Cytomyx/OriGene tissue sample selected is one-of-a-kind and is not available by any other vendor (proprietary to the Cytomyx/OriGene). These particular samples have been identified to compliment a specific set of parameters set forth in ongoing studies conducted by the Laboratory of Translational Genomics at the NCI. Additional matching samples /cases are only available via Cytomyx/OriGene. Cytomyx/OriGene tissue samples are high quality samples collected and stored with rigorous quality control standards and tracked via a robust inventory management system and meet the specifications outlined above. All Cytomyx/OriGene tissue samples are from European ancestry which is crucial to the study. Market research indicates that Cytomyx/OriGene is the only company that can provide sufficient numbers of fresh frozen normal human tissue samples from pancreatic and prostate tissues that fulfill the specifications outlined above. While other companies do sell human tissues, they have limited inventory and do not meet all required specifications. This is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow the researcher to determine if the party can meet this requirement. One (1) original and one (1) copy of the capability statement must be received in the contracting office by 11: 00 a.m. EST on September 18, 2009. All questions must be in writing and can be faxed to 301-402-4513 or sent via email to Karri Mares maresk@mail.nih.gov. It is the vendor’s responsibility to ensure questions have been received by the contract specialist. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractor must have valid, updated registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Application (ORCA). Please reference solicitation No. NCI-90241-KM on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-90241-KM/listing.html)
- Record
- SN01940246-W 20090905/090904001917-d0e0aa44098eff1d5cb95df2a10b2cbb (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |